Company / EPS (Diluted)
Bone Biologics Corp EPS (Diluted) History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.47
FY2020
5-year range
-$1.81 / $0.02
FY2017-FY2020
Trend
+46.6%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.81 to $-0.47 over the past 2 years.
Based on SEC 10-K filings.
-0.47 in FY2020.
Improved from $-1.81 to $-0.47 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, eps (diluted) increased 46.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$0.47 | +46.6% |
| FY2019 | -$0.88 | +51.4% |
| FY2018 | -$1.81 | -9150.0% |
| FY2017 | $0.02 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026